Genenta Science S.p.A. (GNTA)
Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. Its lead product candidate, Temferon, was developed using its platform and carries an interferon-alpha payload. The company was founded by Pierluigi Paracchi, Luigi Naldini and Bernhard Gentner on July 24, 2014 and is headquartered in Milan, Italy.
Address
OLGETTINA, NO. 58
MILAN, L6 20132
Founded
2014
Number of Employees
14
Website
http://www.genenta.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)